Psychopharmacologic management of opioid-dependent women during pregnancy

American Journal on Addictions

Volumn 18, Issue 2, 2009, Pages 148-156

  Martin, Peter R ^a   Arria, Amelia M ^b   Fischer, Gabriele ^c   Kaltenbach, Karol ^d   Heil, Sarah H ^e   Stine, Susan M ^f   Coyle, Mara G ^g   Selby, Peter ^h   Jones, Hendree E ⁱ  

^a Psychiatric Hospital at Vanderbilt   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g BROWN UNIVERSITY   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; ILLICIT DRUG; METHADONE; MOOD STABILIZER; NEUROLEPTIC AGENT; NEUROTRANSMITTER UPTAKE INHIBITOR; OPIATE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; COMORBIDITY; DEPRESSION; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MATERNAL BEHAVIOR; MENTAL DISEASE; OPIATE ADDICTION; PREGNANCY COMPLICATION; RISK BENEFIT ANALYSIS; TREATMENT PLANNING; ANXIETY DISORDER; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; MULTICENTER STUDY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANXIETY DISORDERS; BIPOLAR DISORDER; DEPRESSION; FEMALE; HUMANS; MENTAL DISORDERS; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS;

EID: 66549120324     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490902772975     Document Type: Article

References (62)

1. Jones HE, Martin PR, Heil SH, et al. Treatment of opioid-dependent pregnant women: Clinical and research issues. J Subst Abuse Treat. In press.
2. National Institute on Drug Abuse. National Pregnancy and Health Survey: Drug use among women delivering live births: 1992. 1996.
3. Sander SC, Hays LR. Prescription opioid-dependence and treatment with methadone in pregnancy. J Opioid Manage. 2005;1:91-97.
4. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: patterns and trends in nonmedical prescription pain reliever use: 2002 to 2005. Rockville, MD; April 6, 2007.
5. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: substance use during pregnancy: 2002 and 2003 update. Rockville, MD; June 2, 2005.
6. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Medication-assisted treatment for opioid addiction during pregnancy.In: Bataki SL, Kauffman JF, Marion I, Parrino MW, Woody GE, Center for Substance Abuse Treatment. Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol TIP; no. 43). Rockville, MD; 2005:211-224.
7. Fischer G, Treatment of opioid dependence in pregnant women. Addiction. 2000;95:1141-1144.
8. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birthweight. Addiction. 1997;92:1571-1579.
9. Hulse GK, Milne E, English DR, Homan CD. Assessing the relationship between maternal opiate use and neonatal mortality. Addiction. 1998;93:1033-1042.
10. Kandall SR, Doberczak TM, Jantunen M, Stein J. The methadone-maintained pregnancy. Clin Perinatol. 1999;26:173-183.
11. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obstet Gynecol Clin North Am. 1998;25:139-151.
12. McCarthy JJ, Leamon MH, Parr MS, Anania B. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol. 2005;193:606-610.
13. Fajemirokun-Odudeyi O, Sinha C, Tutty S, et al. Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol. 2006;126:170-175.
14. Johnson RE, Jaffe JH, Fudala PJ. A controlled trial of buprenorphine treatment for opioid dependence. JAMA. 1992;267:2750-2755.
15. Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. Buprenorphine treatment of opioid dependence: clinical trial of daily vs. alternate-day dosing. Drug Alcohol Depend. 1995;40:27-35.
16. Ling W, Wesson DR, Charuvastra C, Klett J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry. 1996;53:401-407.
17. Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70:S87-S101.
18. Jones HE, Johnson RE, Jasinski DR, Milio L. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Drug Alcohol Depend. 2005;78:33-38.
19. Fischer G, Ortner R, Rohrmeister K, et al. Methadone vs. buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006;101:275-281.
20. Cox JL. Psychiatric morbidity and pregnancy: a controlled study of 263 semi-rural Ugandan women. B J Psychiatry. 1979;134:401-405.
21. Evans J, Heron J, Francomb H, Oke S, Golding J. Cohort study of depressed mood during pregnancy and after childbirth. BMJ. 2001;323:257-260.
22. Kennare R, Heard A, Chan A. Substance use during pregnancy: risk factors and obstetric and perinatal outcomes in South Australia. Aust N Z J Obstet Gynaecol. 2005;45:220-225.
23. Fitzsimons HE, Tuten M, Vaidya V, Jones HE. Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat. 2007;32:19-25.
24. Cutrona CE. Causal attributions and perinatal depression. J Abnorm Psychol. 1983;92:161-172.
25. Gotlib IH, Whiffen VE, Mount JH, Milne K, Cordy NI. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol. 1989;57:269-274.
26. Holcomb WL Jr, Stone LS, Lustman PJ, Gavard JA, Mostello DJ. Screening for depression in pregnancy: characteristics of the Beck Depression Inventory. Obstet Gynecol. 1996;88:1021-1025.
27. O'Hara MW. Social support, life events, and depression during pregnancy and the puerperium. Arch Gen Psychiatry. 1986:43:569-573.
28. Pajulo M, Savonlahti E, Sourander A, Helenius H, Piha J. Antenatal depression, substance dependency and social support. J Affect Disord. 2001;65:9-17.
29. Cott AD, Wisner KL. Psychiatric disorders during pregnancy. Int Rev Psychiatry. 2003;15:217-230.
30. Hilty DM, Kelly RH, Hales RE. Diagnosis and treatment of bipolar disorder in pregnant women. Primary Care Update for OB/GYNs. 2000;7:105-112.
31. Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol. 2000;95:487-490.
32. Steer RA, Scholl TO, Hediger ML, Fischer RL. Self-reported depression and negative pregnancy outcomes. J Clin Epidemiol. 1992;45:1093-1099.
33. Gotlib, IH, Whiffen VE. Prospective investigation of postpartum depression: factors involved in onset and recovery. J Abnorm Psychol. 1991;100:122-132.
34. Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Womens Ment Health. 2005;8:77-87.
35. Weinberg MK, Tronick EZ. The impact of maternal psychiatric illness on infant development. J Clin Psychiatry. 1998;59:53-61.
36. Zuckerman B, Amaro H, Bauchner H, Coral H. Depressive symptoms during pregnancy: Relationship to poor health behaviors. Am J Obstet Gynecol. 1989;160:1107-1111.
37. Kelly RH, Danielsen BH, Golding JM, Anders TF, Gilbert WM, Zatzick DF. Adequacy of prenatal care among women with psychiatric diagnoses giving birth in California in 1994 and 1995. Psychiatr Serv. 1999;50:1584-1590.
38. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month DSM-IIIR psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
39. Jones HJ, Arria AM, Baewert A, et al. Evolution and innovation in the agonist treatment of opioid-dependent pregnant women: Development of a multi-center randomized controlled clinical trial (submitted).
40. Jones HE, Johnson RE, Jasinski DR, et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend. 2005;79: 1-10.
41. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV Axis I disorders. Biometrics Research, New York State Psychiatric Institute. New York, NY; 1996.
42. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22-23.
43. Hides L, Lubman DI, Devlin H, et al. Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users. Aust N Z J Psychiatry. 2007;41:166-168.
44. Chiang S, Chan H-Y, Chang Y-Y, Sun J-J, Chen WJ, Chen C-K. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry Clin Neurosci. 2007;61:105-111.
45. Gunter TD, Black DW, Zwick J, Arndt S. Drug and alcohol treatment services effective for methamphetamine abuse. Ann Clin Psychiatry. 2004;16:195-200.
46. Mitchell JD, Brown ES, Rush AJ. Comorbid disorders in patients with bipolar disorder and concomitant substance dependence. J Affect Disord. 2007;102:281-287.
47. American Academy on Pediatrics. Committee on Drugs. Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Pediatrics. 2000;105:880-887.
48. Nulman I, Rovet J, Stewart DE, et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study. Am J Psychiatry. 2002;159:1889-1895.
49. Cohen LS, Rosenbaum JF. Psychotropic drug use during pregnancy: weighing the risks. J Clin Psychiatry. 1998;59:18-28.
50. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:85-102.
51. Battle CL, Zlotnick C, Miller IW, Pearlstein T, Howard M. Clinical characteristics of perinatal psychiatric patients: a chart review study. J Nerv Ment Dis. 2006;194:369-377.
52. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics. 2004;113:368-375.
53. Moses-Kolko EL, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors. JAMA. 2005;293:2372-2383.
54. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New Eng J of Med. 2006;354:579-587.
55. Hollon SD, Stewart MO, Strunk D. Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol. 2006;57:285-315.
56. DeRubreis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs. medication in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62:409-416.
57. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression. The TORDIA randomized controlled trial. JAMA. 2008;299:901-913.
58. Hollon SD, DeRubreis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs. medications in moderate to severe depression. Arch Gen Psychiatry. 2005;62:417-422.
59. Draper JC, McCance-Katz EF. Medical illness and comorbidities in drug users: implications for addiction pharmacotherapy treatment. Subst Use Misuse. 2005;40:1899-1921.
60. Hamilton SP, Nunes EV, Janal M, Weber L. The effect of setraline on methadone plasma levels in methadone-maintenance patients. Am J Addict. 2000;9:63-69.
61. Torrens M, Castillo C, San L, del Moral E, Gonzalez ML, de la Torre R. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. Drug Alcohol Depend. 1998;52:193-200.
62. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence. JAMA. 2004;291:1887-1896.